title: Infliximab and prednisolone: too much of a good thing?
authors.forename: Craig J
authors.initials: CJ
authors.lastname: McClain
authors.forename: Daniell B
authors.initials: DB
authors.lastname: Hill
authors.forename: Shirish S
authors.initials: SS
authors.lastname: Barve
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D006519:Hepatitis, Alcoholic / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D011239:Prednisolone / Q000008:administration & dosage*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone; D000069285:Infliximab